436 research outputs found
An automatic deep learning approach for coronary artery calcium segmentation
Coronary artery calcium (CAC) is a significant marker of atherosclerosis and
cardiovascular events. In this work we present a system for the automatic
quantification of calcium score in ECG-triggered non-contrast enhanced cardiac
computed tomography (CT) images. The proposed system uses a supervised deep
learning algorithm, i.e. convolutional neural network (CNN) for the
segmentation and classification of candidate lesions as coronary or not,
previously extracted in the region of the heart using a cardiac atlas. We
trained our network with 45 CT volumes; 18 volumes were used to validate the
model and 56 to test it. Individual lesions were detected with a sensitivity of
91.24%, a specificity of 95.37% and a positive predicted value (PPV) of 90.5%;
comparing calcium score obtained by the system and calcium score manually
evaluated by an expert operator, a Pearson coefficient of 0.983 was obtained. A
high agreement (Cohen's k = 0.879) between manual and automatic risk prediction
was also observed. These results demonstrated that convolutional neural
networks can be effectively applied for the automatic segmentation and
classification of coronary calcifications
A distal renal tubular acidosis showing hyperammonemia and hyperlactacidemia
Introduction: distal renal tubular acidosis (dRTA) presents itself with variable clinical manifestations and often with late expressions that impact on prognosis. Case report: A 45-day-old male infant was admitted with stopping growth, difficult feeding and vomiting after meals. Clinical tests and labs revealed a type 1 renal tubular acidosis, even if the first blood tests showed ammonium and lactate increase. We had to exclude metabolic diseases before having a certain diagnosis. Conclusions: blood and urine investigations and genetic tests are fundamental to formulate dRTA diagnosis and to plan follow-up, according to possible phenotypic expressions of recessive and dominant autosomal forms in patients with dRTA
Systematic differences between BNP immunoassays: comparison of methods using standard protocols and quality control materials
Background: Recent studies suggested that there are marked systematic differences among BNP immunoassays.
In this study we compared the BNP data and clinical results obtained with different immunoassays, including a
new method (ST-AIA-PACK, TOSOH Corporation).
Methods: BNP was measured on plasma-EDTA samples of healthy subjects (HS, n = 126) and patients with
heart failure (HF, n = 31 NYHA I, II; n = 46 NYHA III, IV) using the ST-AIA-PACK and the Triage Biosite
(Beckman Coulter) methods. Control samples distributed in the CardioOrmoCheck external quality assessment
were also measured with TOSOH and the most used BNP immunoassays in Italy.
Results: TOSOH method showed a good correlation (R = 0.976; n = 327) but a mean bias (−46.9%) compared
to Triage Biosite. On the base of the results obtained in 10 samples of the CardioOrmoCheck study, TOSOH
method showed a strict agreementwith ADVIA Centaur, while it underestimated BNP in comparisonwith Triage
(−52.5%) and ARCHITECT methods (−39.4%). The agreement of ST-AIA-PACK and Triage Biosite methods for
classification of HF patients was tested using 100 ng/L of BNP; the positive agreement between methods was
65%, overall agreement was 73%.
Conclusions: Our results confirm that there are marked differences in measured values among commercial
methods for BNP assay
A distal renal tubular acidosis showing hyperammonemia and hyperlactacidemia.
Introduction: distal renal tubular acidosis (dRTA) presents itself with variable clinical manifestations and often with late expressions that impact on prognosis. Case report: A 45-day-old male infant was admitted with stopping growth, difficult feeding and vomiting after meals. Clinical tests and labs revealed a type 1 renal tubular acidosis, even if the first blood tests showed ammonium and lactate increase. We had to exclude metabolic diseases before having a certain diagnosis. Conclusions: blood and urine investigations and genetic tests are fundamental to formulate dRTA diagnosis and to plan follow-up, according to possible phenotypic expressions of recessive and dominant autosomal forms in patients with dRTA
Cidadania e diversidade em saúde: necessidades e estratégias de promoção de equidade nos cuidados
Este artigo introduz o conceito de cidadania associado à sua concretização no âmbito da saúde em contextos de diversidade. Conjuga resultados de vários projetos de investigação de cariz qualitativo como forma de ilustrar algumas das estratégias concebi‐ das pelo Estado e pela sociedade civil em resposta às mudanças trazidas pelas migrações internacionais. Assim, identificam‐se as necessidades da população, as barreiras de acesso aos cuidados de saúde, as principais fontes de desigualdades e iniquidade e algumas das estratégias desenvolvidas na promoção da equidade em saúde, alertando para a impor‐ tância de levar em consideração as questões culturais e as de índole socioeconómica
D-Dimer as Biomarker for Early Prediction of Clinical Outcomes in Patients With Severe Invasive Infections Due to Streptococcus Pneumoniae and Neisseria Meningitidis
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection; no current clinical measure adequately reflects the concept of dysregulated response. Coagulation plays a pivotal role in the normal response to pathogens (immunothrombosis), thus the evolution toward sepsis-induced coagulopathy could be individuate through coagulation/fibrinolysis-related biomarkers. We focused on the role of D-dimer assessed within 24 h after admission in predicting clinical outcomes in a cohort of 270 patients hospitalized in a 79 months period for meningitis and/or bloodstream infections due to Streptococcus pneumoniae (n = 162) or Neisseria meningitidis (n = 108). Comparisons were performed with unpaired t-test, Mann-Whitney-test or chi-squared-test with continuity correction, as appropriate, and multivariable logistic regression analysis was performed with Bayesian model averaging. In-hospital mortality was 14.8% for the overall population, significantly higher in S. pneumoniae than in N. meningitidis patients: 19.1 vs. 8.3%, respectively (p = 0.014). At univariable logistic regression analysis the following variables were significantly associated with in-hospital mortality: pneumococcal etiology, female sex, age, ICU admission, SOFA score, septic shock, MODS, and D-dimer levels. At multivariable analysis D-dimer showed an effect only in N. meningitidis subgroup: as 500 ng/mL of D-dimer increased, the probability of unfavorable outcome increased on average by 4%. Median D-dimer was significantly higher in N. meningitidis than in S. pneumoniae patients (1,314 vs. 1,055 ng/mL, p = 0.009). For N. meningitidis in-hospital mortality was 0% for D-dimer 7,000 ng/mL. Kaplan-Meier analysis of in-hospital mortality showed for N. meningitidis infections a statistically significant difference for D-dimer >7,000 ng/mL compared to values <500 ng/mL (p = 0.021) and 500\u20133,000 ng/mL (p = 0.002). For S. pneumoniae the mortality risk resulted always high, over 10%, irrespective by D-dimer values. In conclusion, D-dimer is rapid to be obtained, at low cost and available everywhere, and can help stratify the risk of in-hospital mortality and complications in patients with invasive infections due to N. meningitidis: D-dimer <500 ng/mL excludes any further complications, and a cut-off of 7,000 ng/mL seems able to predict a significantly increased mortality risk from much <10% to over 25%
Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience
The emerging outbreak of the coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread worldwide. We prescribed some promising medication to our patients with mild to moderate pneumonia due to SARS-CoV-2, however such drugs as chloroquine, hydrossichloroquine, azithromycin, antivirals (lopinavir/ritonavir, darunavir/cobicistat) and immunomodulating agents (steroids, tocilizumab) were not confirmed as effective against SARS-CoV2. We, therefore, started to use auto-hemotherapy treated with an oxygen/ozone (O2/O3) gaseous mixture as adjuvant therapy. In Udine University Hospital (Italy) we performed a case\u2013control study involving hospitalized adult patients with confirmed COVID-19 with mild to moderate pneumonia. Clinical presentations are based upon clinical phenotypes identified by the Italian Society of Emergency and Urgency Medicine (SIMEU\u2014Societ\ue0 Italiana di Medicina di Emergenza-Urgenza) and patients that met criteria of phenotypes 2 to 4 were treated with best available therapy (BAT), with or without O3-autohemotherapy. 60 patients were enrolled in the study: 30 patients treated with BAT and O2/O3 mixture, as adjuvant therapy and 30 controls treated with BAT only. In the group treated with O3-autohemotherapy plus BAT, patients were younger but with more severe clinical phenotypes. A decrease of SIMEU clinical phenotypes was observed (2.70 \ub1 0.67 vs. 2.35 \ub1 0.88, p = 0.002) in all patients during hospitalization but this clinical improvement\ua0was statistically significant only in O3-treated patients (2.87 \ub1 0.78 vs. 2.27 \ub1 0.83, p < 0.001), differently to the control group (2.53 \ub1 0.51 vs. 2.43 \ub1 0.93, p = 0.522). No adverse events were observed associated with the application of O2/O3 gaseous mixture. O2/O3 therapy as adjuvant therapy could be useful in mild to moderate pneumonia due to SARS-CoV-2. Randomized prospective study is ongoing [Clinical Trials.gov ID: Z7C2CA5837]
- …